Abstract
Patients with atrial fibrillation (AF) who are prescribed oral anticoagulants (OACs) for stroke and systemic embolism (SSE) prevention are frequently nonadherent to therapy. Uncertainty remains about the association between nonadherence and the risk of SSE and death. The objective of this study was to quantify the association between nonadherence to OACs and its clinical consequences.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
